Literature DB >> 10321246

SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter.

D Trotti1, A Rolfs, N C Danbolt, R H Brown, M A Hediger.   

Abstract

The mechanism by which Cu2+/Zn2+ superoxide dismutase (SOD1) mutants lead to motor neuron degeneration in familial amyotrophic lateral sclerosis (FALS) is unknown. We show that oxidative reactions triggered by hydrogen peroxide and catalyzed by A4V and I113T mutant but not wild-type SOD1 inactivated the glutamate transporter human GLT1. Chelation of the copper ion of the prosthetic group of A4V prevented GLT1 inhibition. GLT1 was a selective target of oxidation mediated by SOD1 mutants, and its reactivity was confined to the intracellular carboxyl-terminal domain. The antioxidant Mn(III)TBAP rescued GLT1 from inhibition. Because inactivation of GLT1 results in neuronal degeneration, we propose that toxic properties of SOD1 mutants lead to neuronal death via an excitotoxic mechanism in SOD1-linked FALS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10321246     DOI: 10.1038/8091

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  61 in total

1.  Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease.

Authors:  B K Vanselow; B U Keller
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

2.  Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC.

Authors:  Jason M B Wilson; Iraj Khabazian; David V Pow; Ulla K Craig; Christopher A Shaw
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 3.  Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy.

Authors:  Nicola J Allen; Ragnhildur Káradóttir; David Attwell
Journal:  Pflugers Arch       Date:  2004-08-24       Impact factor: 3.657

4.  Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration.

Authors:  Y H Gong; A S Parsadanian; A Andreeva; W D Snider; J L Elliott
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

5.  Spectroscopic and computational investigation of three Cys-to-Ser mutants of nickel superoxide dismutase: insight into the roles played by the Cys2 and Cys6 active-site residues.

Authors:  Olivia E Johnson; Kelly C Ryan; Michael J Maroney; Thomas C Brunold
Journal:  J Biol Inorg Chem       Date:  2010-03-24       Impact factor: 3.358

6.  Neutralizing aspartate 83 modifies substrate translocation of excitatory amino acid transporter 3 (EAAT3) glutamate transporters.

Authors:  Jasmin Hotzy; Jan-Philipp Machtens; Christoph Fahlke
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

7.  Effects of Tongue Force Training on Bulbar Motor Function in the Female SOD1-G93A Rat Model of Amyotrophic Lateral Sclerosis.

Authors:  Delin Ma; Jeffrey M Shuler; Aishwarya Kumar; Quincy R Stanford; Sudheer Tungtur; Hiroshi Nishimune; John A Stanford
Journal:  Neurorehabil Neural Repair       Date:  2016-09-24       Impact factor: 3.919

Review 8.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders.

Authors:  Serena Carra; Paola Rusmini; Valeria Crippa; Elisa Giorgetti; Alessandra Boncoraglio; Riccardo Cristofani; Maximillian Naujock; Melanie Meister; Melania Minoia; Harm H Kampinga; Angelo Poletti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-03-25       Impact factor: 6.237

10.  Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2).

Authors:  Zao-zhong Su; Magdalena Leszczyniecka; Dong-chul Kang; Devanand Sarkar; Wei Chao; David J Volsky; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.